Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aveo Pharmaceuticals Inc.
DescriptionHigh affinity inhibitory antibody specific to Notch 3
Molecular Target Notch 3 (NOTCH3)
Mechanism of ActionAntibody; Notch inhibitor
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today